Jeffrey M. Gelfand, MD
Jeffrey M. Gelfand, MD
UCSF Department of Neurology
Verified email at - Homepage
Cited by
Cited by
A clinical approach to diagnosis of autoimmune encephalitis
F Graus, MJ Titulaer, R Balu, S Benseler, CG Bien, T Cellucci, I Cortese, ...
The Lancet Neurology 15 (4), 391-404, 2016
The WASOG sarcoidosis organ assessment instrument: an update of a previous clinical tool
MA Judson, U Costabel, M Drent, A Wells, L Maier, L Koth, H Shigemitsu, ...
Sarcoidosis Vasc Diffuse Lung Dis 31 (1), 19-27, 2014
Clemastine fumarate as a remyelinating therapy for multiple sclerosis (ReBUILD): a randomised, controlled, double-blind, crossover trial
AJ Green, JM Gelfand, BA Cree, C Bevan, WJ Boscardin, F Mei, J Inman, ...
The Lancet 390 (10111), 2481-2489, 2017
Long‐term evolution of multiple sclerosis disability in the treatment era
University of California, San Francisco MS‐EPIC Team:, BAC Cree, ...
Annals of neurology 80 (4), 499-510, 2016
Encephalitis and GABAB receptor antibodies: novel findings in a new case series of 20 patients
R Höftberger, MJ Titulaer, L Sabater, B Dome, A Rózsás, B Hegedus, ...
Neurology 81 (17), 1500-1506, 2013
Encephalitis and antibodies to dipeptidyl‐peptidase–like protein‐6, a subunit of Kv4. 2 potassium channels
A Boronat, JM Gelfand, N Gresa‐Arribas, HY Jeong, M Walsh, K Roberts, ...
Annals of neurology 73 (1), 120-128, 2013
Microcystic macular oedema in multiple sclerosis is associated with disease severity
JM Gelfand, R Nolan, DM Schwartz, J Graves, AJ Green
Brain 135 (6), 1786-1793, 2012
Microcystic macular oedema, thickness of the inner nuclear layer of the retina, and disease characteristics in multiple sclerosis: a retrospective study
S Saidha, ES Sotirchos, MA Ibrahim, CM Crainiceanu, JM Gelfand, ...
The Lancet Neurology 11 (11), 963-972, 2012
The importance of early immunotherapy in patients with faciobrachial dystonic seizures
J Thompson, M Bi, AG Murchison, M Makuch, CG Bien, K Chu, ...
Brain 141 (2), 348-356, 2018
Spinal cord gray matter atrophy correlates with multiple sclerosis disability
R Schlaeger, N Papinutto, V Panara, C Bevan, IV Lobach, M Bucci, ...
Annals of neurology 76 (4), 568-580, 2014
Remote physical activity monitoring in neurological disease: a systematic review
VAJ Block, E Pitsch, P Tahir, BAC Cree, DD Allen, JM Gelfand
PloS one 11 (4), e0154335, 2016
Multiple sclerosis: diagnosis, differential diagnosis, and clinical presentation
JM Gelfand
Handbook of clinical neurology 122, 269-290, 2014
Cell‐surface central nervous system autoantibodies: clinical relevance and emerging paradigms
SR Irani, JM Gelfand, A Al‐Diwani, A Vincent
Annals of neurology 76 (2), 168-184, 2014
Ocrelizumab and other CD20+ B-cell-depleting therapies in multiple sclerosis
JM Gelfand, BAC Cree, SL Hauser
Neurotherapeutics 14 (4), 835-841, 2017
Development of a Glucocorticoid Toxicity Index (GTI) using multicriteria decision analysis
EM Miloslavsky, RP Naden, JWJ Bijlsma, PA Brogan, ES Brown, ...
Annals of the rheumatic diseases 76 (3), 543-546, 2017
Individuals with progranulin haploinsufficiency exhibit features of neuronal ceroid lipofuscinosis
ME Ward, R Chen, HY Huang, C Ludwig, M Telpoukhovskaia, A Taubes, ...
Science translational medicine 9 (385), eaah5642, 2017
Infliximab for the treatment of CNS sarcoidosis: a multi-institutional series
JM Gelfand, MJ Bradshaw, BJ Stern, DB Clifford, Y Wang, TA Cho, ...
Neurology 89 (20), 2092-2100, 2017
Timing of retinal neuronal and axonal loss in MS: a longitudinal OCT study
LJ Balk, A Cruz-Herranz, P Albrecht, S Arnow, JM Gelfand, P Tewarie, ...
Journal of neurology 263, 1323-1331, 2016
Diagnosing Balamuthia mandrillaris Encephalitis With Metagenomic Deep Sequencing
MR Wilson, NM Shanbhag, MJ Reid, NS Singhal, JM Gelfand, HA Sample, ...
Annals of neurology 78 (5), 722-730, 2015
Retinal axonal loss begins early in the course of multiple sclerosis and is similar between progressive phenotypes
JM Gelfand, DS Goodin, WJ Boscardin, R Nolan, A Cuneo, AJ Green
PloS one 7 (5), e36847, 2012
The system can't perform the operation now. Try again later.
Articles 1–20